Records 1 - 16 (of 16 Records)
|Query Trace: Colorectal Neoplasms and meta-analysis and PIK3CA[original query]|
| PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Jun 23 (6): 1518-25.
Mao C, Yang Z Y, Hu X F, Chen Q, Tang J
| Phosphatidylinositol-3-kinase pathway aberrations in gastric and colorectal cancer: meta-analysis, co-occurrence and ethnic variation.
International journal of cancer. Journal international du cancer 2014 Mar 134 (5): 1232-8.
Chong Mei-Ling, Loh Marie, Thakkar Bhavin, Pang Brendan, Iacopetta Barry, Soong Rich
| Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a systematic review with meta-analysis.
International journal of cancer. Journal international du cancer 2013 Mar .
Yang ZY, Wu XY, Huang YF, Di MY, Zheng DY, Chen JZ, Ding H, Mao C, Tang JL
| PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis.
Journal of cancer research and clinical oncology 2013 May 139 (5): 891-900.
Wu Shuangjie, Gan Yu, Wang Xinhai, Liu Jun, Li Mengjun, Tang Yif
| Anti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients.
Archives of medical science : AMS 2014 Feb 10 (1): 1-9.
Huang Lulu, Liu Zhenfang, Deng Donghong, Tan Aihua, Liao Ming, Mo Zengnan, Yang Xiao
| The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
Acta oncologica (Stockholm, Sweden) 2014 Jul 53 (7): 852-64.
Therkildsen Christina, Bergmann Troels K, Henrichsen-Schnack Tine, Ladelund Steen, Nilbert M
| PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2015 Dec .
Paleari L, Puntoni M, Clavarezza M, DeCensi M, Cuzick J, DeCensi
| Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies.
OncoTargets and therapy 0 8 3265-3276.
Tang Jie-Ting, Wang Zhen-Hua, Fang Jing-Yu
| Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy.
World journal of gastroenterology 2016 Aug 22 (30): 6944-54.
Lo Nigro Cristiana, Ricci Vincenzo, Vivenza Daniela, Granetto Cristina, Fabozzi Teresa, Miraglio Emanuela, Merlano Marco
| Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2016 Jul .
Mei Z, Duan C, Li C, Cui L, Ogino
| Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis.
Translational oncology 2018 8 11 (5): 1188-1201.
Advani Shailesh M, Advani Pragati, DeSantis Stacia M, Brown Derek, VonVille Helena M, Lam Michael, Loree Jonathan M, Mehrvarz Sarshekeh Amir, Bressler Jan, Lopez David S, Daniel Carrie R, Swartz Michael D, Kopetz Sco
| Mutations of key driver genes in colorectal cancer progression and metastasis.
Cancer metastasis reviews 2018 Jan .
Huang Dongdong, Sun Wenjie, Zhou Yuwei, Li Peiwei, Chen Fang, Chen Hanwen, Xia Dajing, Xu Enping, Lai Maode, Wu Yihua, Zhang Hong
| PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis.
Acta oncologica (Stockholm, Sweden) 2019 9 59 (1): 66-74.
Jin Juan, Shi Yaqin, Zhang Shu, Yang Shuof
| Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis.
Scientific reports 2020 10 10 (1): 18713.
Tabibzadeh Alireza, Tameshkel Fahimeh Safarnezhad, Moradi Yousef, Soltani Saber, Moradi-Lakeh Maziar, Ashrafi G Hossein, Motamed Nima, Zamani Farhad, Motevalian Seyed Abbas, Panahi Mahshid, Esghaei Maryam, Ajdarkosh Hossein, Mousavi-Jarrahi Alireza, Niya Mohammad Hadi Karbala
| Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer.
Targeted oncology 2022 Jun .
Tan Elaine S, Fan Wenyi, Knepper Todd C, Schell Michael J, Sahin Ibrahim H, Fleming Jason B, Xie H
| Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
BMC cancer 2023 11 23 (1): 1117.
Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: